Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 14

1.

Combining functional and structural genomics to sample the essential Burkholderia structome.

Baugh L, Gallagher LA, Patrapuvich R, Clifton MC, Gardberg AS, Edwards TE, Armour B, Begley DW, Dieterich SH, Dranow DM, Abendroth J, Fairman JW, Fox D 3rd, Staker BL, Phan I, Gillespie A, Choi R, Nakazawa-Hewitt S, Nguyen MT, Napuli A, Barrett L, Buchko GW, Stacy R, Myler PJ, Stewart LJ, Manoil C, Van Voorhis WC.

PLoS One. 2013;8(1):e53851. doi: 10.1371/journal.pone.0053851. Epub 2013 Jan 31.

PMID:
23382856
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

[Development of antituberculous drugs: current status and future prospects].

Tomioka H, Namba K.

Kekkaku. 2006 Dec;81(12):753-74. Review. Japanese.

PMID:
17240921
[PubMed - indexed for MEDLINE]
3.

The Seattle Structural Genomics Center for Infectious Disease (SSGCID).

Myler PJ, Stacy R, Stewart L, Staker BL, Van Voorhis WC, Varani G, Buchko GW.

Infect Disord Drug Targets. 2009 Nov;9(5):493-506. Review.

PMID:
19594426
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Genetics and function of the capsules of Burkholderia pseudomallei and their potential as therapeutic targets.

Reckseidler-Zenteno SL, Moore R, Woods DE.

Mini Rev Med Chem. 2009 Feb;9(2):265-71. Review.

PMID:
19200030
[PubMed - indexed for MEDLINE]
5.

Development of Burkholderia mallei and pseudomallei vaccines.

Silva EB, Dow SW.

Front Cell Infect Microbiol. 2013 Mar 11;3:10. doi: 10.3389/fcimb.2013.00010. eCollection 2013. Review.

PMID:
23508691
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Pathogenesis of Burkholderia pseudomallei and Burkholderia mallei.

Larsen JC, Johnson NH.

Mil Med. 2009 Jun;174(6):647-51. Review.

PMID:
19585782
[PubMed - indexed for MEDLINE]
7.

Antibiotic treatment for Burkholderia cepacia complex in people with cystic fibrosis experiencing a pulmonary exacerbation.

Horsley A, Jones AM.

Cochrane Database Syst Rev. 2012 Oct 17;10:CD009529. doi: 10.1002/14651858.CD009529.pub2. Review.

PMID:
23076960
[PubMed - indexed for MEDLINE]
8.

Structural genomics and drug discovery for infectious diseases.

Anderson WF.

Infect Disord Drug Targets. 2009 Nov;9(5):507-17. Review.

PMID:
19860716
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Target selection for structural genomics: an overview.

Marsden RL, Orengo CA.

Methods Mol Biol. 2008;426:3-25. doi: 10.1007/978-1-60327-058-8_1. Review.

PMID:
18542854
[PubMed - indexed for MEDLINE]
10.

Benefits of structural genomics for drug discovery research.

Grabowski M, Chruszcz M, Zimmerman MD, Kirillova O, Minor W.

Infect Disord Drug Targets. 2009 Nov;9(5):459-74. Review.

PMID:
19594422
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Ratiocinative screen of eukaryotic integral membrane protein expression and solubilization for structure determination.

Hays FA, Roe-Zurz Z, Li M, Kelly L, Gruswitz F, Sali A, Stroud RM.

J Struct Funct Genomics. 2009 Mar;10(1):9-16. doi: 10.1007/s10969-008-9046-7. Epub 2008 Nov 22. Review.

PMID:
19031011
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Computational approaches to predicting essential proteins: a survey.

Wang J, Peng W, Wu FX.

Proteomics Clin Appl. 2013 Jan;7(1-2):181-92. doi: 10.1002/prca.201200068. Review.

PMID:
23165920
[PubMed - indexed for MEDLINE]
13.

Rapid analysis of pharmacology for infectious diseases.

Hopkins AL, Bickerton GR, Carruthers IM, Boyer SK, Rubin H, Overington JP.

Curr Top Med Chem. 2011;11(10):1292-300. Review.

PMID:
21401504
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

The ENCODE project and perspectives on pathways.

Tragante V, Moore JH, Asselbergs FW.

Genet Epidemiol. 2014 May;38(4):275-80. doi: 10.1002/gepi.21802. Epub 2014 Apr 10. Review.

PMID:
24723339
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk